Refine your search
-
Authors
-
Item types
-
Topics
- *Adenosine Monophosphate/aa [Analogs & Derivatives]
- *Adenosine/aa [Analogs & Derivatives]
- *Advisory Committees
- *Blood Platelets/de [Drug Effects]
- *Congresses as Topic
- *Coronary Artery Disease/dt [Drug Therapy]
- *Coronary Disease/dt [Drug Therapy]
- *Drug Approval/og [Organization & Administration]
- *Piperazines/tu [Therapeutic Use]
- *Platelet Aggregation/de [Drug Effects]
- *Purinergic P2Y Receptor Antagonists/tu [Therapeutic Use]
- *Thiophenes/tu [Therapeutic Use]
- *United States Food and Drug Administration
- Adenosine Monophosphate/pd [Pharmacology]
- Adenosine/tu [Therapeutic Use]
- Clinical Trials as Topic
- Dose-Response Relationship, Drug
- Drug Therapy, Combination
- Humans
- Purinergic P2Y Receptor Antagonists/pd [Pharmacology]
- Show more
- Show less
-
Collections
-
Languages